Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the stress-like and other aversive consequences of drug abuse, such as withdrawal from alcohol. Two CRH receptors, Crhr1 and Crhr2, have been identified in the mouse. Crhr1 is highly expressed in the anterior pituitary, neocortex, hippocampus, amygdala and cerebellum, and activation of this receptor stimulates adenylate cyclase. Here we show that in mice lacking Crhr1, the medulla of the adrenal gland is atrophied and stress-induced release of adrenocorticotropic hormone (ACTH) and corticosterone is reduced. The homozygous mutants exhibit increased exploratory activity and reduced anxiety-related behaviour under both basal conditions and following alcohol withdrawal. Our results demonstrate a key role of the Crhr1 receptor in mediating the stress response and anxiety-related behaviour.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, plasma corticosterone levels in Crhr1 KO mice were significantly less than those of WT mice after forced-swim stress (15).”
From Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation (2000) · cites this paper as [15]
In the citing paper
“CRF 1 overexpression results in an anxiogenic-and depressive-like profile in rodents and humans [342][343][344][345][346].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [343]
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142 · cited 1×
“CRH functions as the prime mediator in stress-induced hypothalamic-pituitary-adrenal (HPA) axis activation by triggering the immediate release of ACTH from the anterior pituitar”
BackgroundCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946
Chalmers, D., Lovenberg, T., & De Souza, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06340.1995 · Cited by 919
Gene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Swanson, L. W., & Simmons, D. M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902850402 · Cited by 478
Stenzel-Poore, M., Heinrichs, S., Rivest, S., Koob, G., & Vale, W. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468
Cited by
Items 701–800 of 1,000
Molecular biology of the HPA axis
Abel, K.-B., & Majzoub, J. A. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80008-2 · Cited by 10
Chen, Y., Sheng, H., Xu, Y., Zhang, Y., & Ni, X. (2012) · Neuropeptides · doi:10.1016/j.npep.2011.12.004 · Cited by 10
Li, D., London, S. J., Liu, J., Lee, W.-U., Jiang, X., Berg, D. V. D., Bergen, A. W., Nishita, D., Waleh, N., Swan, G. E., et al. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq471 · Cited by 10
Guzman, R. M. D., Rosinger, Z. J., Rybka, K. A., Jacobskind, J. S., Thrasher, C. A., Caballero, A. L., Sturm, K. L., Sharif, M. S., Abbas, M. S., Parra, K. E., et al. (2023) · Neuroendocrinology · doi:10.1159/000530156 · Cited by 9
Malan‐Müller, S., Fairbairn, L., Hart, S. A., Daniels, W. M. U., Dashti, M. J. S., Kidd, M., Seedat, S., Gamieldien, J., & Hemmings, S. M. J. (2017) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000176 · Cited by 9
“It has been used effectively to facilitate extinction learning in rats when administered before or immediately after extinction training (Walker et al., 2002; Ledgerwood et al., 2003, 2005; Yang and Lu, 2005; Philbert et al., 2013).”
BackgroundMethodNalivaiko, E., & Blessing, W. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00818-7 · Cited by 9
Hypothalamo-hypophysial system in rats with autotransplantation of the adrenal cortex
Takizawa, N., Tanaka, S., Oe, S., Koike, T., Matsuda, T., & Yamada, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6375 · Cited by 9
“The stress-induc-ible ACTH secretion from the anterior pituitary corticotrophs is impaired in Crhr1 −/− mice (18,19).”
Bandelow, B., & Wedekind, D. (2006) · Springer eBooks · doi:10.1007/3-540-30887-3_11 · Cited by 9
Pournajafi‐Nazarloo, H., Partoo, L., Sanzenbacher, L., Azizi, F., & Carter, C. S. (2007) · Neuroendocrinology · doi:10.1159/000103587 · Cited by 9
Molekulare Mechanismen der Depressionstherapie
Holsboer, F. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_9 · Cited by 9
Self-citationThe effects of corticotropin-releasing factor on motor learning
Takeuchi, E., Hatanaka, T., Iijima, T., Kimura, M., & Katoh, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-66736-0 · Cited by 8
Molecular characterization, expression and functional analysis of yak IFITM3 gene
Wang, H., Wang, L., Li, J., Fu, F., Zheng, Y., & Zhang, L. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.057 · Cited by 8
“And these characteristics can cause changes in the body’s immune function [24-26].”
BackgroundAso, K., Kobayashi, K., Mochizuki, M., Kanzaki, N., Sako, Y., & Yano, T. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.086 · Cited by 8
Fan, J., Chen, X., Wang, X., Hao, K., & Du, J.-Z. (2014) · PubMed · Cited by 8
Psychiatric Disorders - New Frontiers in Affective Disorders
Schoepf, D. (2013) · InTech eBooks · doi:10.5772/2039 · Cited by 8
Ueyama, T., Sato, K., Kakimoto, S., Houtani, T., Sakuma, S., Ohishi, H., Kase, M., & Sugimoto, T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02079-x · Cited by 8
Gould, T. D., & Manji, H. K. (2003) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377251.lg05 · Cited by 8
Elgiushy, H. R., Abou-Taleb, N. A., Holz, G. G., Chepurny, O. G., Pirmettis, I. C., Kakabakos, S. E., Karageorgos, V., Liapakis, G., Albohy, A., Abouzid, K. A. M., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105079 · Cited by 7
Banerjee, P., Chau, K. M., Kotla, S., Davis, E. L., Turcios, E. B., Li, S., Zhang, P., Wang, G., Kolluru, G. K., Jain, A., et al. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01223-5 · Cited by 7
“Mice lacking CRFR1 exhibit reduced anxiety-related behavior [285, 286], implicating CRFR1 in psychiatric disorders and as a target for anxiety and depression treatment.”
Chang, S., & Deussing, J. M. (2021) · Masterclass in neuroendocrinology · doi:10.1007/978-3-030-86630-3_9 · Cited by 7
CRF1 receptor-deficiency induces anxiety-like vulnerability to cocaine
Morisot, N., Millan, M. J., & Contarino, A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3534-1 · Cited by 7
Post-traumatic Stress Disorder and Substance Use Disorders
Roberts, M. E., Moore, S. D., & Beckham, J. C. (2007) · Elsevier eBooks · doi:10.1016/b978-012370632-4/50019-x · Cited by 7
Xu, Y., & Tong, Q. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.09.027 · Cited by 7
Helman, T. J., Headrick, J. P., Peart, J. N., & Stapelberg, N. J. C. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15747 · Cited by 7
“Excessive CRH activity induces anxiety/depression related signalling via CRH receptor 1 (Liebsch et al., 1999), with deficiency in the receptor reducing anxiogenesis in mice (Timpl et al., 1998).”
BackgroundCRF antagonists as novel treatment strategies for stress-related disorders
Steckler, T. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80065-3 · Cited by 7
Self-citationNigawara, T., HORIBA, N., TOZAWA, F., Kasagi, Y., Uchida, K., Iwasaki, Y., & Suda, T. (2003) · Pituitary · doi:10.1023/b:pitu.0000004796.71734.e4 · Cited by 7
“HPA response [32,33], implicating the role of this receptor in the behavioral control system.”
BackgroundCorticotrophin-releasing hormone decreases synaptic transmission in rat sensorimotor cortex in vivo
Froc, D. J., & Christie, B. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.004 · Cited by 7
Chapter 3. New developments in the study of corticotropin releasing factor
Saunders, J., & Williams, J. P. (2001) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(01)36043-8 · Cited by 7
Altered emotional behaviors in the diabetes mellitus OLETF type 1 congenic rat
Watanabe, A., Okuno, S., Okano, M., Jordan, S., Aihara, K., Watanabe, T., Yamasaki, Y., Kitagawa, H., Sugawara, K., & Kato, S. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.075 · Cited by 7
Warnock, G., Moechars, D., Langlois, X., & Steckler, T. (2009) · Peptides · doi:10.1016/j.peptides.2009.01.005 · Cited by 7
Self-citationRoy, A., & Roy, R. N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00017-6 · Cited by 7
Bagosi, Z., Csabafi, K., Karasz, G., Jászberényi, M., Földesi, I., Siska, A., Szabó, G., & Telegdy, G. (2018) · Peptides · doi:10.1016/j.peptides.2018.10.014 · Cited by 6
“Both lines showed an attenuated response to restraint stress with a minimal increase in plasma ACTH and CORT levels, suggesting an important role for CRFR1 in initiating HPA axis activation [37,38].”
Kunzel, H. E., Kluge, M., Zeising, M., Schopohl, J., Yassouridis, A., Stalla, G. K., & Steiger, A. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.06.029 · Cited by 6
Self-citationRole of Basolateral Amygdalar Somatostatin 2 Receptors in a Rat Model of Chronic Anxiety
Gaskins, D. L., Burke, A. R., Sajdyk, T. J., Truitt, W. A., Dietrich, A. D., & Shekhar, A. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.08.031 · Cited by 6
Sun, Y., Chen, Q., Cui, W., Chen, H., Zhao, J., & Rong, J. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae167 · Cited by 6
Riester, A., Spyroglou, A., Neufeld-Cohen, A., Chen, A., & Beuschlein, F. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0144 · Cited by 6
“Animals deficient for CRFR1 have an impaired stress response (Smith et al. 1998, Timpl et al. 1998) and decreased anxiety-like behavior (Smith et al. 1998) and fail to display the characteristic HPA axis response to restraint stress.”
BackgroundBases biochimiques et neurobiologiques de la psychiatrie
de Beaurepaire, R. (2004) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/j.emcps.2004.07.003 · Cited by 6
Gehlert, D. R., Cramer, J. W., & Morin, S. M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189753 · Cited by 6
“Whereas the role of CRF at the level of the pituitary is well established (Timpl et al., 1998; Preil et al., 2001), CRF also has distinct actions via the central nervous system (Müller et al., 2003).”
InfluentialGene Targeting Studies of Hyperexcitability and Affective States of Alcohol Withdrawal in Rodents
Greenberg, G. D., & Crabbe, J. C. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.010 · Cited by 6
New Pharmacological Treatment Approaches for Anxiety Disorders
Ströhle, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_18 · Cited by 6
Fedeli, A., Policani, F., Ubaldi, M., Cippitelli, A., Massi, M., & Ciccocioppo, R. (2006) · Peptides · doi:10.1016/j.peptides.2006.09.001 · Cited by 6
Tiermodelle für Angst und Angststörungen
Pawlak, C. R., & Weyers, P. (2006) · Psychologische Rundschau · doi:10.1026/0033-3042.57.3.139 · Cited by 6
Genetic Transmission of Behavior and Its Neuroendocrine Correlates
Hambsch, B., Landgraf, R., Czibere, L., & Touma, C. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00084-x · Cited by 6
Emerging targets for the treatment of depressive disorder
Young, A. H., & Macritchie, K. (2001) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.5.5.601 · Cited by 6
“Targets (2001) 5(5) stress and anxiety responses [38].”
BackgroundCushing’s syndrome: drug targets and therapeutic options
Páez-Pereda, M., ARZT, E. S., & Stalla, G. K. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.10.1537 · Cited by 6
“The CRH receptor Type I has been shown to play an important role in stress, but it is not needed for basal ACTH production [19].”
BackgroundSelf-citationAssociation between stress pathway gene (CRHR1⧹CRHBP) polymorphisms and heroin dependence
Su, H., Wang, Z., & Zhao, M. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.05.009 · Cited by 6
Molecular characterization, expression and anti-tumor function analysis of yak IFITM2 gene
Wang, H., Wang, L., Luo, X., Guan, J., Zhang, X., Zhang, L., & Xiang, Y. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.212 · Cited by 5
Animal Models for Anxiety Disorders
Guo, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-79251-4_9 · Cited by 5
Lalonde, R., & Strazielle, C. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0075 · Cited by 5
“and shorter latencies to enter the lit compartment (Timpl et al., 1998), as did conditional Crhr1 null mutant mice lacking CRHR1 specifically in the limbic system”
BackgroundSakoguchi, T., Horiuchi, M., Asakawa, A., Ushikai, M., Yoshida, G., Fujimiya, M., Kato, I., Nakazato, M., Takeuchi, T., Saheki, T., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.001 · Cited by 5
CRH-Receptors and their Ligands
Maier, C., Kotzmann, H., & Luger, A. (2003) · Endocrine updates · doi:10.1007/978-1-4615-0501-3_4 · Cited by 5
Koch, C. A., & Stratakis, C. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012373947-6.00171-9 · Cited by 5
Schatz, K. C., Agajanov, M., Varlinskaya, E. I., & Diaz, M. R. (2026) · Addiction Neuroscience · doi:10.1016/j.addicn.2026.100257 · Cited by 4
Protect and harm: Effects of stress on the amygdala
(2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-815134-1.00011-8 · Cited by 5
Kothandapani, A., Larsen, M. C., Lee, J., Jorgensen, J. S., & Jefcoate, C. R. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111265 · Cited by 4
Tanaka, M., Tomimatsu, Y., Sakimura, K., Ootani, Y., Sako, Y., Kojima, T., Aso, K., Yano, T., & Hirai, K. (2017) · Peptides · doi:10.1016/j.peptides.2017.06.009 · Cited by 4
Selective antagonism of CRF1 receptor by a substituted pyrimidine
Sakellaris, S., Matsoukas, M., Karageorgos, V., Poulaki, S., Kuppast, B., Margioris, A. N., Venihaki, M., Fahmy, H. T. Y., & Liapakis, G. (2019) · HORMONES · doi:10.1007/s42000-019-00105-9 · Cited by 4
van Tilburg, M. A. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-43268-7_6 · Cited by 4
Ellenbroek, B. A., & Youn, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801657-2.00007-0 · Cited by 4
Corticotropin‐Releasing Factor (CRF) and CRF‐Related Peptides – a Linkage Between Stress and Anxiety
Blank, T., & Spiess, J. (2009) · Wiley eBooks · doi:10.1002/9783527628346.ch8 · Cited by 4
van Tilburg, M. A. L. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-709-9_6 · Cited by 4
Valdez, G. R., Zorrilla, E. P., & Koob, G. F. (2005) · Drug Development Research · doi:10.1002/ddr.20024 · Cited by 4
“Mice lacking a functional CRF1 receptor show a decreased responsiveness to stress [Contarino et al., 1999; Smith et al., 1998; Timpl et al., 1998] and decreased motor activation [Contarino et al.”
InfluentialHypothalamische und hypophysäre Erkrankungen
Renner, U., Schaaf, L., & Stalla, G. K. (2001) · Springer eBooks · doi:10.1007/978-3-642-56858-9_2 · Cited by 4
Self-citationModulation of HPA Axis Function for Treatment of Mood Disorders
Brothers, S. P., Wahlestedt, C., & Nemeroff, C. B. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00276 · Cited by 4
Mutagenesis and Knockout Models: Hypothalamic-Pituitary-Adrenocortical System
Keck, M. E., & Müller, M. B. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_4 · Cited by 4
Genetics of Endocrine-Behavior Interactions
Müller, M. B., Keck, M. E., Steckler, T., & Holsboer, F. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50093-7 · Cited by 4
Self-citationElizabeth A. Hebert, J. M. S., & Dugas, M. J. (2017) · Sage eBooks · doi:10.4135/9781483365817.n761 · Cited by 4
Zieglgänsberger, W., & Spanagel, R. (1999) · Springer eBooks · doi:10.1007/978-3-662-07096-3_8 · Cited by 4
Self-citationPrévot, T. D. (2015) · theses.fr (ABES) · doi:10.70675/ede624f4zd89cz47a2z9b47z4074eaaea9b2 · Cited by 4
Brain‐Wide Patterns of CRF Receptor 1 Expression in the Transgenic CRFR1‐Cre‐2a‐tdTom Rat
Engelke, D. S., Ugartemendia, L., Tao, J., Rajamanickam, S., Monte, F. H. D., & Justice, N. J. (2025) · The Journal of Comparative Neurology · doi:10.1002/cne.70101 · Cited by 3
Ries, C., Štark, T., Boulat, B., Ruhwedel, T., Delling, J. P., Infante, A. M., von Poblotzki, J., Ulivi, A. F., von Mücke-Heim, I.-A., Chang, S., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116474 · Cited by 3
Stk24 deficiency causes disrupted hippocampal neurogenesis and anxiety-like behavior in mice
Wu, K., Tsao, C.-H., Su, N. C., Deng, S., & Huang, G. (2025) · Communications Biology · doi:10.1038/s42003-025-08035-6 · Cited by 3
“Nevertheless, no signi fi cant difference was found in most of the GR signaling-related genes (basal GR: U = 24.00, p > 0.99; basal Fkbp5 : U = 14.00, p = 0.22; basal Gilz : U = 22.00, p = 0.83; stress GR: U = 18.00, p = 0.47; stress Fkbp5 : U = 11.00, p = 0.10; stress Gilz : U = 15.00, p = 0.27), except for Sgk1 (basa…”
InfluentialAnterior Pituitary and Pars Intermedia Space
Romanò, N., & Shipston, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00008-0 · Cited by 3
Molecular regulation of the CRF system
Roseboom, P. H., Kalin, N. H., Steckler, T., & Dautzenberg, F. M. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80011-2 · Cited by 3
Self-citationDevelopmental Aspects of Panic and Related Anxiety Disorders
Hobbs, J. A., & Shekhar, A. (2003) · Neuroembryology and Aging · doi:10.1159/000071023 · Cited by 3
Action of CRF/Urocortin Peptides
Deussing, J. M., Ryabinin, A. E., Zuniga, A., & Kozicz, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00062-6 · Cited by 3
Bases biochimiques et neurobiologiques de la psychiatrie
de Beaurepaire, R. (2005) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(05)16945-4 · Cited by 3
(2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80049-5 · Cited by 3
Belzung, C., Leman, S., & Griebel, G. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00015-x · Cited by 3
HPA Axis Function During the Perinatal Period in Patients with Affective Disorders
Leff, P., Cruz-Fuentes, C. S., Reyes‐Grajeda, J. P., Mancilla‐Herrera, I., López‐Martínez, M., Bustos, R. G., Gomez, M. L. M., & Flores‐Ramos, M. (2015) · Current Psychiatry Reviews · doi:10.2174/1573400511666150407224518 · Cited by 3
de Miguel, E., Vekovischeva, O. Y., Elsilä, L. V., Panhelainen, A. E., Kankuri, E. M., Aitta‐aho, T., & Korpi, E. R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00130 · Cited by 3
Behavioral and Molecular Aspects of Alcohol Craving and Relapse
Spanagel, R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_15 · Cited by 3
Self-citationPromises and Limitations of Transgenic and Knockout Mice in Modeling Psychiatric Symptoms
Holmes, A., & Crawley, J. N. (2000) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-4860-4_5 · Cited by 3
Bunck, M. (2008) · doi:10.5282/edoc.9109 · Cited by 3
Ullrich, M. (2014) · Online Publication Service of Würzburg University (Würzburg University) · Cited by 3
Lessons Learned from Gene Targeting and Transgenesis for Adrenal Physiology and Disease
Böttner, A., & Bornstein, S. R. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1011568516406 · Cited by 3
Bold female zebrafish (Danio rerio) have physiological advantages in reproductive performance
Hu, Y., & Liu, Y. (2025) · Hormones and Behavior · doi:10.1016/j.yhbeh.2025.105858 · Cited by 2
Counterregulatory Deficiencies in Diabetes
McCrimmon, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch3 · Cited by 2
CRF-1 Corticotropin-Releasing Factor Receptor
Dautzenberg, F. M., & Hauger, R. L. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60149-7 · Cited by 2
Piccin, A., Allain, A., Baufreton, J., Bertrand, S. S., & Contarino, A. (2024) · eLife · doi:10.7554/elife.100849.3 · Cited by 2
Role of corticotropin-releasing hormone receptor 1 in the regulation of nociception in mice
Park, S.-H., Choi, S.-S., Sim, Y., Lee, J.-K., & Suh, H. (2014) · Animal Cells and Systems · doi:10.1080/19768354.2014.966857 · Cited by 2
“The activation of CRHR1 in the hypothalamus is primarily responsible for the regulation of Adrenocorticotropic hormone secretion from the pituitary and a variety of behavioral and autonomic response changes to stress (Timpl et al. 1998; Aguilera et al. 2004).”
BackgroundKATUGAMPOLA, S. D., Fish, R. L., Wood, C., Young, K., & Mathews, C. D. C. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.06.002 · Cited by 2
Kumar, K. A., Satyanarayana, S., & Kilari, E. K. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312460069 · Cited by 2
Holsboer‐Trachsler, E., & Holsboer, F. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_53 · Cited by 2
Self-citationWagner, U., & Born, J. (2010) · Springer eBooks · doi:10.1007/978-3-540-72340-0_7 · Cited by 2
Bishop, L. (2015) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Pharmacological and behavioral characterization of the novel CRF1 antagonist BMS-763534
Lodge, N. J., Lelas, S., Li, Y.-W., Molski, T. F. P., Grace, J. E., Sivarao, D. V., Post-Munson, D. J., Healy, F. L., Bronson, J. J., Hartz, R. A., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.025 · Cited by 2
Hormones, Stress and Depression
Müller, M. B., & Holsboer, F. (2005) · Springer eBooks · doi:10.1007/3-540-26940-1_13 · Cited by 2
Self-citationModeling and testing compulsive eating behaviors in animals
Moore, C. F., Cheng, J. E., Sabino, V., & Cottone, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816207-1.00012-3 · Cited by 2
Dautzenberg, F. M., Grigoriadis, D. E., Hauger, R. L., Risbrough, V. B., Steckler, T., Vale, W., & Valentino, R. J. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f19/2019.4 · Cited by 2
Self-citation
Metadata
- Authors
- Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Helmholtz Munich (DE)
- Corresponding author
- Wurst, Wolfgang
- Venue
- Nature Genetics
- Published
- 1998-06
- Volume
- 19
- Issue
- 2
- Pages
- 162-166
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/520
- OpenAlex
- W1572525448
- Semantic Scholar
- 963e2500bc129b9bfedf1ae198ec17a73626fcdc
- Cited by
- 919
- References
- 32
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 6 · 2022: 14 · 2021: 16 · 2020: 9 · 2019: 20 · 2018: 23 · 2017: 20 · 2016: 27 · 2015: 24 · 2014: 31 · 2013: 27 · 2012: 47
- FWCI
- 22.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Site cant be reached (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- corticotropin-releasing hormone receptor 1, stress response, anxiety-like behavior, ACTH, corticosterone, alcohol withdrawal, exploratory activity, CRH receptor 2, adenylate cyclase
- MeSH terms
- CRF Receptor, Type 1, Adrenocorticotropic Hormone, Ethanol, Animals, Anxiety, Cells, Cultured, Corticosterone, Pituitary Gland, Stress, Physiological, Substance Withdrawal Syndrome, In Situ Hybridization, Receptors, Corticotropin-Releasing Hormone, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.